FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10150511000001100: Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32180101000001110 Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
43167001000001117 Aldactone 200mg/10ml solution for injection ampoules (Imported (Germany)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Is a Potassium canrenoate 200mg/10ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has active ingredient Potassium canrenoate true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has specific active ingredient Potassium canrenoate true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) 10 ampoule Is pack of False Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Inferred relationship Existential restriction modifier
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) 10 ampoule Has AMP True Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start